Regeneron Pharmaceuticals
REGN
REGN
658 hedge funds and large institutions have $23.1B invested in Regeneron Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 243 increasing their positions, 258 reducing their positions, and 111 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
24% less capital invested
Capital invested by funds: $30.4B → $23.1B (-$7.27B)
42% less first-time investments, than exits
New positions opened: 64 | Existing positions closed: 111
55% less funds holding in top 10
Funds holding in top 10: 11 → 5 (-6)
Holders
658
Holding in Top 10
5
Calls
$507M
Puts
$646M
Top Buyers
| 1 | +$391M | |
| 2 | +$190M | |
| 3 | +$151M | |
| 4 |
Parnassus Investments
San Francisco,
California
|
+$146M |
| 5 |
Millennium Management
New York
|
+$138M |
Top Sellers
| 1 | -$384M | |
| 2 | -$318M | |
| 3 | -$298M | |
| 4 |
JP Morgan Chase
New York
|
-$231M |
| 5 |
DCP
DSM Capital Partners
Palm Beach Gardens,
Florida
|
-$154M |